Home / News & Media / Validated Excellence! Shandong New-Line Bio Honored as Provincial "Specialized, Refined, Differential and Innovative" (SRDI) SME

Validated Excellence! Shandong New-Line Bio Honored as Provincial "Specialized, Refined, Differential and Innovative" (SRDI) SME

📅 Date: 2026-07-27 🏢 Source: New-Line Bio ✍️ Author: Admin
Executive Summary

Shandong New-Line Biotechnology Co., Ltd. has been officially awarded the prestigious title of "Specialized, Refined, Differential and Innovative" (SRDI) Small and Medium Enterprise by the Shandong Provincial Department of Industry and Information Technology, affirming our technological leadership in agricultural bacteriophage manufacturing.

Validated Excellence! Shandong New-Line Bio Honored as Shandong Province "Specialized, Refined, Differential and Innovative" (SRDI) SME

Date: 2026-07-28 | Source: New-Line Bio Corporate News

Accreditation Announcement: The Shandong Provincial Department of Industry and Information Technology officially released the 2026 List of Specialized, Refined, Differential and Innovative (SRDI) Enterprises. Shandong New-Line Biotechnology Co., Ltd. successfully earned this high-level provincial accreditation following rigorous multi-tier evaluation.

The "Specialized, Refined, Differential and Innovative" designation is an authoritative state and provincial certification that honors enterprises exhibiting deep specialization in strategic niche industries, refined craftsmanship and quality management, unique technological capabilities, and cutting-edge continuous innovation.

Since its inception in 2018 with a registered capital of RMB 80 million, Shandong New-Line Bio has concentrated on bacteriophage biological technology to address the escalating challenge of antimicrobial resistance (AMR) in animal husbandry. In close collaboration with the Jiangsu Academy of Agricultural Sciences and the International Phage Research Center (IPRC), New-Line Bio has established a multi-disciplinary R&D team led by over 30 PhD and Master researchers.

This recognition will further accelerate New-Line Bio's investments in automated continuous fermentation, novel endolysin engineering, and international clinical trials, solidifying our mission to provide sustainable, zero-residue green solutions for global animal health and food safety.